Here, we used the FVBN202 transgenic mouse model of neu-overexpressing breast cancer and the FVB parental strain to investigate the state of local and distant tumor dormancy during early stage breast cancer, as well as the role of the immune response or chemotherapy in controlling tumor dormancy and preventing tumor relapse. This evidence concerns the gene ERBB2 and neoplasm.